If your institution subscribes to this resource, and you don't have a MyAccess Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Human epidermal growth factor receptor 2 (HER2)–directed monoclonal antibody
HER2-overexpressing breast cancer; metastatic gastric or gastroesophageal junction adenocarcinoma
Biosimilar [not interchangeable] for trastuzumab# (RITUXAN);79 trastuzumab-dkst#* (OGIVRI),80 trastuzumab-pkrb#* (HERZUMA)81, pertuzumab#
Chapter 67. Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules > Trastuzumab
eChapter 2018: The Goodman & Gilman Year in Review New and Noteworthy FDA Approvals